Pulmonary Arterial Hypertension Market Overview and Developments by 2024

Pulmonary Arterial Hypertension (PAH) Market Current Trends, Size,

Share, Industry Analysis, Competitive Intelligence, Growth, Opportunities

and Forecasts To 2024

Summary

Pulmonary Arterial Hypertension (PAH) is a rare and severe condition characterized by vascular

proliferation and remodeling of the small pulmonary arteries. This results in progressively

increasing pulmonary vascular resistance, leading to an increase in pulmonary arterial pressure.

The disease typically results in right-sided heart failure and premature death. PAH can be

idiopathic, heritable, or associated with different conditions such as connective tissue disease

(CTD), congenital heart disease (CHD), human immunodeficiency virus (HIV) infection, and

exposure to toxins or drugs. PAH occurs twice as frequently in women as in men.

GlobalData epidemiologists forecast an increase in the diagnosed incident cases of PAH in the

7MM, from 1,769 diagnosed incident cases in 2014 to 1,838 diagnosed incident cases in 2024,

with an Annual Growth Rate (AGR) of 0.39% during the forecast period. In 2024, the US will

have the highest number of diagnosed incident cases of PAH in the 7MM, with 677 diagnosed

incident cases, whereas the UK will have the lowest number of diagnosed incident cases of PAH,

with 74 diagnosed incident cases. Similarly, the diagnosed prevalent cases of PAH in the 7MM

are expected to increase from 9,926 diagnosed prevalent cases in 2014 to 10,285 diagnosed

prevalent cases in 2024, with an AGR of 0.36% during the forecast period. In 2024, the US will

have the highest number of diagnosed prevalent cases of PAH in the 7MM, with 4,325 diagnosed

prevalent cases, whereas the UK will have the lowest number of diagnosed prevalent cases of

PAH, with 443 diagnosed prevalent cases.

Browse the full “Pulmonary Arterial Hypertension (PAH) Market” report at:

http://www.radiantinsights.com/research/epicast-report-pulmonary-arterial-hypertensionepidemiology-forecast-to-2024...